$0.516
-0.051 (-9.88%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Rani Therapeutics Holdings Inc (RANI) Moving Averages Convergence Divergence (MACD) indicator is -0.06, suggesting RANI is Strong sell.
Rani Therapeutics Holdings Inc (RANI) 20-Day simple moving average is 0.63, while Rani Therapeutics Holdings Inc (RANI) share price is $—, making it Sell.
Rani Therapeutics Holdings Inc (RANI) 60-Day simple moving average is 0.76, while Rani Therapeutics Holdings Inc (RANI) share price is $—, making it Sell.
Technical Analysis for RANI
AI Technical RANIAs of 2026-11-03, the technical board for Rani Therapeutics Holdings Inc (RANI) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $0.52 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 26.921, MACD stands at -0.0574 (Sell), Stochastic %K stands at 7.672 (Buy), Stochastic %D stands at 6.237 and CCI stands at -122.471 (Buy).
RANI trades below the 60-day SMA (0.76) and below the 200-day SMA (0.92). Immediate resistance sits at Classic R1 0.64, then R2 0.69. Support sits at Classic S1 0.52, then S2 0.45.
Rani Therapeutics Holdings Inc (RANI) Support & Resistance Level
Rani Therapeutics Holdings Inc (RANI) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 26.921 |
| STOCHk_14_3_3 | 7.672 |
| STOCHd_14_3_3 | 6.237 |
| CCI_20 | -122.471 |
| AO_5_34 | -0.133 |
| MOM_10 | -0.071 |
| MACD_12_26_9 | -0.057 |
Rani Therapeutics Holdings Inc (RANI) Relative Strength Index (RSI_14) is 26.921, creating a Buy signal.
Rani Therapeutics Holdings Inc (RANI) Stochastic %K is 7.672, creating a Buy signal.
Rani Therapeutics Holdings Inc (RANI) Stochastic %D is 6.237, creating a Buy signal.
Rani Therapeutics Holdings Inc (RANI) CCI_20 is -122.471, creating a Buy signal.
Rani Therapeutics Holdings Inc (RANI) Awesome Oscillator (AO) is -0.133, creating a Sell signal.
Rani Therapeutics Holdings Inc (RANI) Momentum (MOM) is -0.071, creating a Sell signal.
Rani Therapeutics Holdings Inc (RANI) Moving Average Convergence Divergence (MACD) is -0.057, creating a Sell signal.
Rani Therapeutics Holdings Inc (RANI) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 0.557 | Sell |
| MA_10 | 0.584 | Sell |
| MA_20 | 0.630 | Sell |
| MA_60 | 0.760 | Sell |
| MA_200 | 0.916 | Sell |
| MA_250 | 1.043 | Sell |
Rani Therapeutics Holdings Inc (RANI) 5-Day simple moving average is 0.557, while Rani Therapeutics Holdings Inc (RANI) share price is $, making it a Sell.
Rani Therapeutics Holdings Inc (RANI) 10-Day simple moving average is 0.584, while Rani Therapeutics Holdings Inc (RANI) share price is $, making it a Sell.
Rani Therapeutics Holdings Inc (RANI) 20-Day simple moving average is 0.630, while Rani Therapeutics Holdings Inc (RANI) share price is $, making it a Sell.
Rani Therapeutics Holdings Inc (RANI) 60-Day simple moving average is 0.760, while Rani Therapeutics Holdings Inc (RANI) share price is $, making it a Sell.
Rani Therapeutics Holdings Inc (RANI) 200-Day simple moving average is 0.916, while Rani Therapeutics Holdings Inc (RANI) share price is $, making it a Sell.
Rani Therapeutics Holdings Inc (RANI) 250-Day simple moving average is 1.043, while Rani Therapeutics Holdings Inc (RANI) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.